ask="N/A"
ask_size="N/A"
average_daily_volume="41023"
bid="3.15"
bid_size="100"
book_value="2.04"
change="+0.05"
change_from_200_day_moving_average="-0.47"
change_from_50_day_moving_average="0.12"
change_from_52_week_high="-2.94"
change_From_52_week_low="1.44"
change_in_percent="+0.96%"
close="5.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.73"
ebitda="-18.35M"
eps_estimate_current_year="-1.92"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.86"
ex_dividend_date="N/A"
float_shares="2391000"
high="5.30"
high_52_weeks="8.19"
last_trade_date="3/10/2017"
last_trade_price="5.25"
last_trade_size="669"
last_trade_time="4:00pm"
low="5.15"
low_52_weeks="3.81"
market_capitalization="32.79M"
moving_average_200_day="5.72"
moving_average_50_day="5.13"
name="Aldeyra Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.25"
open="5.25"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-8.16%"
percent_change_from_50_day_moving_average="+2.29%"
percent_change_from_52_week_high="-35.90%"
percent_change_from_52_week_low="+37.80%"
previous_close="5.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.55"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="6245000"
short_ratio="0.47"
stock_exchange="NCM"
symbol="ALDX"
volume="15248"
weeks_range_52="3.81 - 8.19"
